Sepsis Profile Test Price and Details at Chughtai Lab

Sepsis Profile at Chughtai Lab

Sepsis is a life-threatening medical emergency characterized by an extreme, dysregulated host response to an infection, leading to systemic inflammatory response syndrome (SIRS), tissue damage, organ dysfunction, and potentially septic shock or death. The Sepsis Profile at Chughtai Lab is a specialized, comprehensive panel of laboratory investigations designed to rapidly detect systemic infection, evaluate the severity of the inflammatory response, assess vital organ function, and guide targeted therapeutic interventions. This profile integrates multiple diagnostic modalities, combining hematological, biochemical, immunological, and microbiological parameters to provide a holistic view of the patient’s physiological state.

Key components of this diagnostic panel typically include a Complete Blood Count (CBC) with differential to assess leukocyte dynamics, C-Reactive Protein (CRP) and Procalcitonin (PCT) to quantify systemic inflammation, Serum Lactate to evaluate tissue hypoperfusion, and blood cultures to isolate the causative pathogen. Additionally, renal function tests (RFTs), liver function tests (LFTs), and coagulation profiles are incorporated to monitor for multi-organ dysfunction syndrome (MODS), which is a hallmark of severe sepsis. By utilizing state-of-the-art automated analyzers and advanced microbiological culture systems, Chughtai Lab delivers rapid, highly precise results that are critical for clinical decision-making.

The primary benefit of the Sepsis Profile is its ability to deliver rapid, actionable data during the critical early stages of infection. Early administration of appropriate antimicrobial therapy and fluid resuscitation within the “golden hour” of sepsis has been shown to significantly reduce mortality rates. This diagnostic panel serves as an indispensable tool for clinicians, offering a comprehensive physiological snapshot that aids in early diagnosis, risk stratification, and real-time monitoring of treatment efficacy in both emergency and intensive care settings.

Clinical Procedure: What to Expect

Patient Preparation

• No Fasting Required: Since sepsis is an acute, emergency condition, fasting is typically not required for this profile. The test can be performed at any time of the day or night.
• Medication Disclosure: Inform the healthcare provider or phlebotomist about all current medications, especially antibiotics, anticoagulants, or immunosuppressants, as these can influence culture and coagulation results.
• Hydration: Ensure adequate hydration prior to the blood draw to facilitate venous access, unless fluid restriction has been medically advised.
• Comfortable Clothing: Wear loose-fitting clothing with sleeves that can be easily rolled up above the elbow to allow unobstructed access to the venipuncture site.
• Bedside Collection: For critically ill or hospitalized patients, the blood sample is collected at the bedside under strict aseptic conditions by a trained phlebotomist.

During the Procedure

The patient is positioned comfortably, either sitting in a phlebotomy chair or lying down in a hospital bed. The phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. Strict aseptic technique is paramount, especially for blood cultures, to prevent contamination with skin flora. The skin is thoroughly cleansed using an antiseptic solution, such as chlorhexidine gluconate or 70% isopropyl alcohol, and allowed to dry completely. A tourniquet is applied briefly above the selected site to make the vein more prominent, and a sterile needle is inserted into the vein.

Multiple tubes of blood are collected in a specific order of draw to prevent cross-contamination of additives. For blood cultures, two separate sets of bottles (aerobic and anaerobic) are collected from different anatomical sites to maximize pathogen detection rates. Once collection is complete, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to prevent hematoma formation. The entire procedure typically takes 10 to 15 minutes and is generally safe, with minor discomfort or bruising at the needle insertion site being the only common side effects.

When is a Sepsis Profile Performed?

Systemic Inflammatory Response Syndrome (SIRS)

Physicians order a Sepsis Profile when a patient exhibits two or more signs of SIRS in the presence of a suspected or confirmed infection. These signs include a body temperature greater than 38°C or less than 36°C, a heart rate exceeding 90 beats per minute, a respiratory rate greater than 20 breaths per minute, or an abnormal white blood cell count. The profile helps differentiate between non-infectious inflammatory states and true infectious sepsis, allowing for immediate clinical intervention.

Suspected Bacterial or Fungal Bacteremia

When a patient presents with high-grade, spiking fevers, chills, rigors, and altered mental status, bacteremia or fungemia is highly suspected. The Sepsis Profile, particularly through blood culture and sensitivity testing, is critical in these scenarios. It assists in identifying the specific micro-organism circulating in the bloodstream and determining its antimicrobial susceptibility, enabling transition from broad-spectrum empiric therapy to targeted, narrow-spectrum antibiotics.

Unexplained Hypotension and Septic Shock

Septic shock is a severe subset of sepsis characterized by persistent hypotension despite adequate fluid resuscitation, along with tissue hypoperfusion. Clinicians utilize the Sepsis Profile, focusing heavily on serum lactate levels and arterial blood gases, to evaluate the severity of cellular hypoxia and anaerobic metabolism. Elevated lactate levels serve as a critical diagnostic marker and prognostic indicator for septic shock, guiding aggressive fluid resuscitation and vasopressor therapy.

Monitoring Treatment Response in ICU Patients

For critically ill patients admitted to the intensive care unit (ICU) with confirmed sepsis, the profile is performed serially. Monitoring trends in biomarkers like Procalcitonin (PCT) and C-Reactive Protein (CRP), alongside organ function parameters (creatinine, bilirubin, platelet count), allows clinicians to assess whether the patient is responding to the prescribed antimicrobial and supportive therapies. A declining PCT level, for instance, indicates successful source control and resolving infection.

High-Risk Patients with Localized Infections

Patients with localized infections, such as severe pneumonia, complicated urinary tract infections (pyelonephritis), intra-abdominal abscesses, or extensive wound infections, are at high risk of progressing to systemic sepsis. This is especially true for vulnerable populations, including the elderly, neonates, diabetics, and immunocompromised individuals. The Sepsis Profile is performed to detect early systemic involvement and organ stress before clinical deterioration becomes irreversible.

What Does a Sepsis Profile Detect?

• Leukocytosis: An elevated white blood cell count indicating an active immune response to infection.
• Leukopenia: An abnormally low white blood cell count often seen in severe or overwhelming sepsis.
• Neutrophilia: An increased absolute neutrophil count suggesting an acute bacterial infection.
• Bandemia: The presence of immature neutrophils (left shift) indicating intense bone marrow stimulation.
• Lymphopenia: A decreased lymphocyte count reflecting sepsis-induced immune suppression or apoptosis.
• Thrombocytopenia: A low platelet count suggesting consumption coagulopathy or impending disseminated intravascular coagulation (DIC).
• Elevated C-Reactive Protein (CRP): High levels indicating systemic inflammatory response.
• Markedly Elevated Procalcitonin (PCT): Levels highly specific for severe bacterial infections and sepsis.
• Elevated Serum Lactate: Indicating tissue hypoperfusion, cellular hypoxia, and anaerobic glycolysis.
• Hyperglycemia: Elevated blood glucose due to stress-induced cortisol and catecholamine release.
• Hypoglycemia: Low blood glucose, which can occur in neonatal sepsis or end-stage septic shock.
• Elevated Blood Urea Nitrogen (BUN): Indicating acute kidney injury (AKI) or prerenal azotemia.
• Elevated Serum Creatinine: Reflecting impaired renal clearance due to sepsis-induced hypoperfusion.
• Hyperbilirubinemia: Elevated bilirubin indicating hepatic dysfunction or cholestasis secondary to sepsis.
• Elevated Transaminases (ALT/AST): Indicating hepatocellular injury due to hypoperfusion or inflammatory cytokines.
• Prolonged Prothrombin Time (PT): Indicating impairment of the extrinsic coagulation pathway.
• Prolonged Activated Partial Thromboplastin Time (APTT): Indicating impairment of the intrinsic coagulation pathway.
• Elevated International Normalized Ratio (INR): Reflecting systemic coagulation dysfunction.
• Decreased Fibrinogen: Suggesting consumption during disseminated intravascular coagulation (DIC).
• Elevated D-Dimer: Indicating active fibrinolysis and microvascular thrombosis.
• Positive Blood Cultures: Identifying specific bacterial pathogens (e.g., Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae).
• Positive Fungal Cultures: Identifying fungal pathogens (e.g., Candida species) in the bloodstream.
• Metabolic Acidosis: Low pH and bicarbonate levels on arterial blood gas analysis, secondary to lactic acidosis.
• Hypoxemia: Low partial pressure of oxygen indicating pulmonary involvement or acute respiratory distress syndrome (ARDS).
• Hypoalbuminemia: Low serum albumin due to increased capillary permeability and acute-phase protein synthesis shift.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is renowned for its rapid and highly efficient reporting system, which is critical for time-sensitive investigations like the Sepsis Profile. While preliminary results for inflammatory markers (such as CRP and Procalcitonin), complete blood counts, and basic metabolic panels are typically available within a few hours (often 2 to 4 hours) of sample collection, microbiological blood cultures require longer incubation periods. Preliminary blood culture reports are generally updated at 24-hour and 48-hour intervals, with final negative reports issued after 5 days of incubation to ensure no slow-growing pathogens are missed. If a pathogen is detected, the lab immediately performs identification and antibiotic susceptibility testing (AST), which takes an additional 18 to 24 hours.

Patients and referring physicians can easily access reports online through the official Chughtai Lab website or the dedicated Chughtai Healthcare mobile application. Real-time SMS alerts are sent to the registered mobile number as soon as reports are finalized. Additionally, physical copies of the reports can be collected from any of the numerous Chughtai Lab collection centers across Pakistan, or delivered directly via their home sample collection service.

Sepsis Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
White Blood Cell (WBC) Count	4,000 – 11,000 cells/µL	Leukocytosis (>12,000 cells/µL) or Leukopenia (<4,000 cells/µL)
Procalcitonin (PCT)	< 0.1 ng/mL	Elevated (>0.5 ng/mL indicates systemic infection; >2.0 ng/mL high risk of sepsis)
Serum Lactate	< 2.0 mmol/L	Elevated (>2.0 mmol/L indicates hypoperfusion; >4.0 mmol/L indicates septic shock)
Platelet Count	150,000 – 450,000 cells/µL	Thrombocytopenia (<100,000 cells/µL) indicating consumption
C-Reactive Protein (CRP)	< 5.0 mg/L	Markedly elevated (>50 – 100 mg/L) indicating severe inflammation
Serum Creatinine	0.6 – 1.2 mg/dL	Elevated (>1.5 mg/dL) indicating acute kidney injury (AKI)
Blood Culture	No growth after 5 days	Growth of pathogenic bacteria or fungi (e.g., E. coli, S. aureus)
Total Bilirubin	0.2 – 1.2 mg/dL	Elevated (>2.0 mg/dL) indicating sepsis-induced liver dysfunction
Coagulation (INR)	0.8 – 1.2	Elevated (>1.5) indicating systemic coagulopathy or DIC risk

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Sepsis Profile?

• Accredited Laboratory Standards: Chughtai Lab operates under strict quality control protocols, adhering to international standards and holding relevant national and international quality certifications.
• Advanced Diagnostic Technology: Utilizing state-of-the-art automated hematology, biochemistry, and microbiology analyzers to ensure maximum precision and speed.
• Expert Pathologist Oversight: Every Sepsis Profile is supervised and interpreted by highly qualified Consultant Pathologists and Microbiologists, ensuring clinical accuracy.
• Rapid Turnaround Times: Understanding the critical nature of sepsis, Chughtai Lab prioritizes emergency panels, delivering rapid preliminary results for vital biomarkers like lactate and procalcitonin.
• Convenient Home Sample Collection: Offers highly professional, sterile home sample collection services across major cities in Pakistan, bringing critical diagnostic care to the patient’s doorstep.
• Seamless Digital Access: Patients and clinicians can access, download, and track diagnostic reports instantly via the Chughtai Healthcare mobile app and secure online portal.
• Extensive Network of Centers: With a vast network of collection centers and 24/7 operational labs, patients can access diagnostic services whenever and wherever needed.
• Compassionate Patient Care: Dedicated to providing a comfortable, safe, and professional environment for all patients, ensuring a stress-free diagnostic experience.